Feng Chi Biotech Corp. (TPEX:6744)

Feng Chi Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	10.25	17.39	26.25	30.61	65.9	48.81
Short-Term Investments	161.6	160.74	180.93	185.32	169	181.47
Cash & Short-Term Investments	171.85	178.13	207.18	215.93	234.9	230.27
Cash Growth	-10.30%	-14.02%	-4.06%	-8.08%	2.01%	5.03%
Accounts Receivable	20.83	15.33	15.92	14.92	11.54	12.61
Receivables	20.83	15.33	15.92	14.92	11.54	12.61
Inventory	30.53	34.73	19.05	19.04	25.46	20.33
Prepaid Expenses	1.44	3.44	3.27	3.17	0.85	1.16
Other Current Assets	0.2	0.96	0.91	2.15	2.47	1.67
Total Current Assets	224.85	232.59	246.32	255.21	275.22	266.03
Property, Plant & Equipment	3.85	32.88	32.53	27.24	24.29	13.42
Long-Term Investments	45.44	14.56	12.78	11.33	-	-
Other Intangible Assets	0.08	0.11	0.02	0.07	0.13	0.01
Long-Term Deferred Tax Assets	1.59	1.69	1.51	1.67	1.63	1.72
Other Long-Term Assets	5.32	6.08	5.92	5.52	7.1	5.51
Total Assets	281.13	287.91	299.07	301.03	308.36	286.69

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.64	14.24	17.07	12.94	18.78	14.9
Accrued Expenses	-	6.48	6.21	8.08	9.3	8.59
Current Portion of Leases	2.84	2.8	2.72	2.65	2.58	2.55
Current Income Taxes Payable	1.05	0.66	0.18	1.71	2.33	2.17
Current Unearned Revenue	16.17	17.14	22.29	24.17	25.24	23.97
Other Current Liabilities	23.5	3.9	5.13	5.25	3.3	4
Total Current Liabilities	50.18	45.21	53.59	54.8	61.53	56.18
Long-Term Leases	1.2	2.63	5.43	8.15	10.8	-
Long-Term Deferred Tax Liabilities	0.23	0.17	0.18	0.09	0.16	-
Total Liabilities	51.62	48.01	59.19	63.03	72.49	56.18

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	154	154	154	154	154	154
Additional Paid-In Capital	30.05	30.05	30.05	30.05	30.05	30.05
Retained Earnings	45.42	54.09	54.24	53.82	51.82	46.45
Comprehensive Income & Other	0.03	1.76	1.58	0.13	-	-
Shareholders' Equity	229.51	239.9	239.88	238	235.87	230.51
Total Liabilities & Equity	281.13	287.91	299.07	301.03	308.36	286.69

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	4.04	5.43	8.15	10.8	13.38	2.55
Net Cash (Debt)	167.81	172.7	199.03	205.13	221.53	227.72
Net Cash Growth	-9.19%	-13.23%	-2.98%	-7.40%	-2.72%	6.42%
Net Cash Per Share	10.95	11.18	12.87	13.27	14.32	14.73
Filing Date Shares Outstanding	15.25	15.4	15.4	15.4	15.4	15.4
Total Common Shares Outstanding	15.25	15.4	15.4	15.4	15.4	15.4
Working Capital	174.67	187.38	192.74	200.41	213.69	209.85
Book Value Per Share	15.05	15.58	15.58	15.45	15.32	14.97
Tangible Book Value	229.43	239.8	239.86	237.93	235.74	230.5
Tangible Book Value Per Share	15.04	15.57	15.58	15.45	15.31	14.97
Machinery	-	52.92	40.5	30.25	30.41	26
Leasehold Improvements	-	0.11	0.11	0.11	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 19, 2026

Data Sources Report a data error